Παραπομπή σε μορφή APA (7η εκδ.)

Croucher, P., Hijzen, A., Shipman, C., Perry, M., Lippitt, J., Green, J., . . . Vanderkerken, K. (2001). Zoledronic acid inhibits the development of osteolytic bone disease and increases disease free survival in a murine model of multiple myeloma.

Παραπομπή σε μορφή Chicago (17η εκδ.)

Croucher, P., A. Hijzen, C. Shipman, M. Perry, J. Lippitt, J. Green, B. Van Camp, και K. Vanderkerken. Zoledronic Acid Inhibits the Development of Osteolytic Bone Disease and Increases Disease Free Survival in a Murine Model of Multiple Myeloma. 2001.

Παραπομπή σε μορφή MLA (9th εκδ.)

Croucher, P., et al. Zoledronic Acid Inhibits the Development of Osteolytic Bone Disease and Increases Disease Free Survival in a Murine Model of Multiple Myeloma. 2001.